Abstract

High-resolution ultrasonography (HRUS) is an emerging new tool in the investigation of peripheral nerves. We set out to assess the utility of HRUS performed at lower extremity nerves in peripheral neuropathies. Nerves of 26 patients with polyneuropathies of different etiologies and 26 controls were investigated using HRUS. Patients underwent clinical, laboratory, electrophysiological assessment, and a diagnostic sural nerve biopsy as part of the routine work-up. HRUS was performed at the sural, tibial, and the common, superficial, and deep peroneal nerves. The superficial peroneal nerve longitudinal diameter (LD) distinguished best between the groups: patients with immune-mediated neuropathies (n = 13, including six with histology-proven vasculitic neuropathy) had larger LD compared to patients with non-immune-mediated neuropathies (p < 0.05) and to controls (p < 0.001). Among all subgroups, patients with vasculitic neuropathy showed the largest superficial peroneal nerve LD (p < 0.001) and had a larger sural nerve cross-sectional area when compared with disease controls (p < 0.001). Enlargement of the superficial peroneal and sural nerves as detected by HRUS may be a useful additional finding in the differential diagnosis of vasculitic and other immune-mediated neuropathies.

Highlights

  • Diagnosing potentially treatable immune-mediated neuropathies can be challenging, in vasculitic neuropathy, which is one of the most severe, but treatable forms [1]

  • We investigated lower extremity nerves of patients with immunemediated and non-immune-mediated neuropathies of different etiologies and compared data with disease controls and among neuropathy subgroups

  • We showed that neuropathies lead to an enlargement of lower extremity nerves, in general, and that the superficial peroneal nerve longitudinal diameter (LD) may be a useful parameter indicating immune-mediated, and vasculitic neuropathies

Read more

Summary

Introduction

Diagnosing potentially treatable immune-mediated neuropathies can be challenging, in vasculitic neuropathy, which is one of the most severe, but treatable forms [1]. We prospectively studied the utility of HRUS by assessing lower extremity nerves in patients with immune-mediated and non-immune-mediated neuropathies of different etiologies. Of all electrophysiological tests performed during routine patient assessment, we only used the results of conduction studies of the sural nerve that was later biopsied and of the tibial nerve (antidromic recording; surface electrodes) for the present analyses.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call